Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture.

Antimicrobial Agents and Chemotherapy
P C FamillettiS Pestka

Abstract

A myeloblast cell line has proved to be an excellent source of human leukocyte interferon. These cells, primed with interferon and induced with Sendai virus, produced optimal levels of human leukocyte interferon. The cells grew readily in spinner flasks and in medium containing horse serum. Interferon production over several months yielded an average titer of 2 X 10(5) reference units of interferon per 10(7) cells. The interferon produced by these cells appeared to be predominantly species of human leukocyte interferon. Since these cells seemed to consist of myeloblasts, it is clear that cells other than B-lymphocytes can produce leukocyte interferon.

References

Jan 1, 1979·Archives of Virology·P Jameson, S E Grossberg
Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R L CavalieriS Pestka
Feb 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M RubinsteinS Pestka
Jan 1, 1979·Infection and Immunity·L C OsborneH M Johnson
Mar 1, 1979·Antimicrobial Agents and Chemotherapy·F KleinP J Bridgen
Dec 1, 1972·Antimicrobial Agents and Chemotherapy·E A Havell, J Vilcek
Sep 25, 1980·Nucleic Acids Research·D V GoeddelS Pestka
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·W P LevyS Pestka
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S SteinS Pestka
Feb 1, 1981·Journal of Virology·S RubinsteinS Pestka
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S MaedaS Pestka
Feb 1, 1981·Archives of Biochemistry and Biophysics·H J FriesenS Pestka
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T StaehelinS Pestka
Jan 1, 1980·Annals of the New York Academy of Sciences·M EvingerS Pestka
Aug 1, 1981·Archives of Biochemistry and Biophysics·M RubinsteinS Pestka
Jan 1, 1981·Methods in Enzymology·R D HershbergS Pestka
Jan 1, 1981·Methods in Enzymology·D S HobbS Pestka
Jan 1, 1981·Methods in Enzymology·P C FamillettiS Pestka
Jan 1, 1981·Methods in Enzymology·M Evinger, S Pestka
Jan 1, 1981·Methods in Enzymology·A SlomaS Pestka

❮ Previous
Next ❯

Citations

Feb 15, 2001·Biopolymers·S Pestka
Jan 1, 1985·Pharmacology & Therapeutics·S Pestka, S J Tarnowski
Oct 1, 1993·Pharmacology & Therapeutics·P Fitzgerald-Bocarsly
Apr 1, 1997·The International Journal of Biochemistry & Cell Biology·I G IvanovM G Abouhaidar
Jan 1, 1982·Journal of Interferon Research·E Dworkin-RastlP Swetly
Oct 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M HussainM J Liao
Oct 23, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M HussainM J Liao
Jul 27, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Gong ChengZhaoxin Zheng
Jul 1, 1981·Antimicrobial Agents and Chemotherapy·P C Familletti, S Pestka
May 16, 2007·The Journal of Biological Chemistry·Sidney Pestka
Jul 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nathaniel M GreenAnn Marshak-Rothstein
Jan 1, 1986·Journal of Basic Microbiology·M Tonew, B Glück
Jul 1, 1984·The Journal of Investigative Dermatology·J A Langer, S Pestka

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.